Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T07:26:26.631Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of Nosocomial Infection and Antibiotic Use at a University Medical Center in Malaysia

Published online by Cambridge University Press:  21 June 2016

Andrew J. Hughes ,
Norliza Ariffin ,
Tan Lien Huat ,
Habibah Abdul Molok ,
Salbiah Hashim ,
Juliana Sarijo ,
Nor Harlida Abd Latif ,
Yasmin Abu Hanifah  and
Adeeba Kamarulzaman
Andrew J. Hughes*
Affiliation:
Department of Medicine, Geelong Hospital, Victoria, Australia
Norliza Ariffin
Affiliation:
Infectious Diseases Unit, Department of Medicine, Kuala Lumpur, Malaysia
Tan Lien Huat
Affiliation:
Infectious Diseases Unit, Department of Medicine, Kuala Lumpur, Malaysia
Habibah Abdul Molok
Affiliation:
Infection Control Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Salbiah Hashim
Affiliation:
Infection Control Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Juliana Sarijo
Affiliation:
Infection Control Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Nor Harlida Abd Latif
Affiliation:
Infection Control Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Yasmin Abu Hanifah
Affiliation:
Infection Control Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Adeeba Kamarulzaman
Affiliation:
Infectious Diseases Unit, Department of Medicine, Kuala Lumpur, Malaysia
*
91 Camden Road, Newtown, Victoria 3220, Australia
Get access Rights & Permissions [Opens in a new window]

Abstract

Background and Objective:

Most reports of nosocomial infection (NI) prevalence have come from developed countries with established infection control programs. In developing countries, infection control is often not as well established due to lack of staff and resources. We exMnined the rate of N1 in our institution.

Methods:

A point-prevalence study of N1 and antibiotic prescribing was conducted. On July 16 and 17, 2001, all inpatients were surveyed for N1, risk factors, pathogens isolated, and antibiotics prescribed and their indication. NIs were diagnosed according to CDC criteria. Cost of antibiotic acquisition was calculated by treatment indication.

Setting:

Tertiary-care referral center in Malaysia.

Patients:

All inpatients during the time of the study.

Results:

Five hundred thirty-eight patients were surveyed. Seventy-five had 103 NIs for a prevalence of 13.9%. The most common NIs were urinary tract infections (12.29-6), pneumonia (21.4%), laboratory-confirmed bloodstream infections (12.2%), deep surgical wound infections (11.2%), and clinical sepsis (22.4%). Pseudomonas aeruginosa, MRSA, and MSSA were the most common pathogens. Two hundred thirty-seven patients were taking 347 courses of antibiotics, for an overall prevalence of antibiotic use of 44%. N1 treatment accounted for 36% of antibiotic courses prescribed but 47% of antibiotic cost. Cost of antibiotic acquisition for N1 treatment was estimated to be approximately 2 million per year (Malaysian dollars).

Conclusion:

Whereas the rate of N1 is relatively high at our center compared with rates from previous reports, antibiotic use is among the highest reported in any study of this kind. Further research into this high rate of antibiotic use is urgently required.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 1 , January 2005 , pp. 100 - 104
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Starling, C. Infection control in developing countries. Current Opinion in Infectious Diseases 2001;14:461–466.Google Scholar
2.Haley, RW, Culver, DH, White, JW, et al.The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182–205.Google Scholar
3.Weinstein, JW, Mazon, D, Pantelick, E, Reagan-Cirincione, P, Dembry, LM, Hierholzer, WJ. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol 1999;20:543–548.Google Scholar
4.Mayon-White, RT, Ducei, G, Kereselidze, T, Tikomirov, E. An international survey of the prevalence of hospital-acquired infection. J Hosp Infect 1988;11:43–48.Google Scholar
5.Centers for Disease Control and Prevention. National Nosocomial Infection Study Site Definition Manual. Atlanta, GA: Centers for Disease Control and Prevention; 1999.Google Scholar
6.Graham, DR, Keldermans, MM, Klemm, LW, Semenza, NJ, Shafer, ML. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med 1991;91:95S–100S.Google Scholar
7.McGowan, JE Jr, Finland, M. Infection and antibiotic usage at Boston City Hospital: changes in prevalence during the decade 1964-1973. J Infect Dis 1974;129:421–428.CrossRefGoogle ScholarPubMed
8.Meers, PD, Emmerson, AM. Report on the National Survey of Infection in Hospitals, 1980. J Hosp Infect 1981;2(suppl):1–48.Google Scholar
9.Moro, ML, Stazi, MA, Marasca, G, Greco, D, Zampieri, A. National prevalence survey of hospital-acquired infections in Italy, 1983. J Hosp Infect 1986;8:72–85.CrossRefGoogle ScholarPubMed
10.French, GL, Cheng, A, Farrington, M. Prevalence survey of infection in a Hong Kong hospital using a standard protocol and microcomputer data analysis. J Hosp Infect 1987;9:132–142.Google Scholar
11.French, GL, Cheng, AF, Wong, SL, Donnan, S. Repeated prevalence surveys for monitoring effectiveness of hospital infection control. Lancet 1989;2:1021–1023.Google Scholar
12.Sramova, H, Bartonova, A, Bolek, S, Krecmerova, M, Subertova, V. National prevalence survey of hospital-acquired infections in Czechoslovakia. J Hosp Infect 1988;11:328–334.Google Scholar
13.McLaws, ML, Gold, J, King, KIrwig, LM, Berry, G. The prevalence of nosocomial and community-acquired infections in Australian hospitals. Med J Aust 1988;149:582–590.Google Scholar
14.Vaque, J, Rossello, J, Trilla, A, et al.Nosocomial infections in Spain: results of five nationwide serial prevalence surveys (EPINE Project, 1990 to 1994). Nosocomial infections prevalence study in Spain. Infect Control Hosp Epidemiol 1996;17:293–297.Google Scholar
15.Sartor, C, Sambuc, R, Bimar, MC, Gulian, C, De Micco, P. Prevalence surveys of nosocomial infections using a random sampling method in Marseille hospitals. J Hosp Infect 1995;29:209–216.Google Scholar
16.Nicholls, TM, Morris, AJ. Nosocomial infection in Auckland Healthcare hospitals. NZMed J 1997;110:314–316.Google ScholarPubMed